Literature DB >> 7899721

Retinal pathologic changes in multiple sclerosis.

J B Kerrison1, T Flynn, W R Green.   

Abstract

PURPOSE: To describe the ocular pathologic changes in multiple sclerosis (MS), with attention to its effects on the uveal tract and retinal veins.
METHODS: Cases of 26 patients with MS and 3 patients with neuromyelitis optica were reviewed; retinal trypsin digestion was performed on remaining wet tissue for 20 of these patients. Eyes were specifically examined for inflammation of the retinal vessels, uveal tract, retina, optic nerve, and pars plana. Specimens were also examined for atrophy of the optic nerve, ganglion cell, and nerve fiber layers.
RESULTS: Atrophy of the nerve fiber and ganglion cell layers was present in 73% of the cases with MS and correlated with optic nerve atrophy; choroiditis was present in 11.5%; bilateral cyclitis without other foci of inflammation was present in 1 case; and retinal phlebitis was present in 20% (most of which were only identified after trypsin digestion). Optic nerve inflammation was present in two of the patients with neuromyelitis optica.
CONCLUSION: Uveitis and retinal phlebitis are manifestations of MS. Trypsin digestion with microscopic examination is a sensitive method of testing for phlebitis, which may explain why the frequency found in this series is higher than in others. These lesions are similar to the perivenular cuffing that occurs in the central nervous system in MS.

Entities:  

Mesh:

Year:  1994        PMID: 7899721     DOI: 10.1097/00006982-199414050-00010

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  53 in total

1.  Retinal and optic nerve head pathology in Susac's syndrome.

Authors:  D Scott McLeod; Howard S Ying; Colin A McLeod; Rhonda Grebe; Martin Lubow; John O Susac; Gerard A Lutty
Journal:  Ophthalmology       Date:  2011-03       Impact factor: 12.079

Review 2.  Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration.

Authors:  Kristin M Galetta; Peter A Calabresi; Elliot M Frohman; Laura J Balcer
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

3.  Chronic cerebrospinal venous insufficiency in multiple sclerosis: a historical perspective.

Authors:  Michael D Dake; Robert Zivadinov; E Mark Haacke
Journal:  Funct Neurol       Date:  2011 Oct-Dec

4.  In vivo assessment of retinal neuronal layers in multiple sclerosis with manual and automated optical coherence tomography segmentation techniques.

Authors:  Michaela A Seigo; Elias S Sotirchos; Scott Newsome; Aleksandra Babiarz; Christopher Eckstein; E'tona Ford; Jonathan D Oakley; Stephanie B Syc; Teresa C Frohman; John N Ratchford; Laura J Balcer; Elliot M Frohman; Peter A Calabresi; Shiv Saidha
Journal:  J Neurol       Date:  2012-03-15       Impact factor: 4.849

5.  Electroretinographic abnormalities in multiple sclerosis: possible role for retinal autoantibodies.

Authors:  Farzin Forooghian; Melanie Sproule; Carol Westall; Lynn Gordon; Guy Jirawuthiworavong; Kaori Shimazaki; Paul O'Connor
Journal:  Doc Ophthalmol       Date:  2006-09-14       Impact factor: 2.379

6.  Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis.

Authors:  Stephanie B Syc; Shiv Saidha; Scott D Newsome; John N Ratchford; Michael Levy; E'tona Ford; Ciprian M Crainiceanu; Mary K Durbin; Jonathan D Oakley; Scott A Meyer; Elliot M Frohman; Peter A Calabresi
Journal:  Brain       Date:  2011-10-17       Impact factor: 13.501

7.  Diffusion tensor imaging of the optic tracts in multiple sclerosis: association with retinal thinning and visual disability.

Authors:  Hormuzdiyar H Dasenbrock; Seth A Smith; Arzu Ozturk; Sheena K Farrell; Peter A Calabresi; Daniel S Reich
Journal:  J Neuroimaging       Date:  2011-04       Impact factor: 2.486

8.  Microcystic macular oedema in multiple sclerosis is associated with disease severity.

Authors:  Jeffrey M Gelfand; Rachel Nolan; Daniel M Schwartz; Jennifer Graves; Ari J Green
Journal:  Brain       Date:  2012-04-25       Impact factor: 13.501

9.  Optical coherence tomography measures axonal loss in multiple sclerosis independently of optic neuritis.

Authors:  Philipp Albrecht; Ruth Fröhlich; Hans-Peter Hartung; Bernd C Kieseier; Axel Methner
Journal:  J Neurol       Date:  2007-11-09       Impact factor: 4.849

Review 10.  [Diagnosis and monitoring of multiple sclerosis: the value of optical coherence tomography].

Authors:  M Bock; F Paul; J Dörr
Journal:  Nervenarzt       Date:  2013-04       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.